Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,357,765 papers from all fields of science
Search
Sign In
Create Free Account
Repaglinide:PrThr:Pt:Ser/Plas:Ord
Known as:
Repaglinide SerPl Ql
, Repaglinid:MevcE?ik:Zml?:Ser/Plaz:Srl
, Repaglinida:ACnc:Pt:Sor/Plas:Ord
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Plas
Serum
repaglinide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial.
Akihiro Nishimura
,
Shuki Usui
,
+7 authors
T. Hirose
Endocrine journal
2016
Corpus ID: 207430537
Although sitagliptin and repaglinide monotherapies improve postprandial hyperglycemia, the long-term effects and safety of their…
Expand
2013
2013
INFLUENCE OF HYDROXYPROPYL-β-CYCLODEXTRIN ON REPAGLINIDE RELEASE FROM SUSTAINED RELEASE BIOADHESIVE BUCCAL TABLETS
Y. MadhusudanRao
,
P. Pavankumar
,
K. Sunitha
,
K. Harika
2013
Corpus ID: 220659353
Objective: The purpose of this investigation was to study the influence of cyclodextrin complexation on development of sustained…
Expand
2011
2011
Dimethylaminopyridine repaglinide eutectic
张建军
,
郝君
,
高缘
,
齐宣
2011
Corpus ID: 146489859
The invention relates to a dimethylaminopyridine repaglinide eutectic formed through combining dimethylaminopyridine with…
Expand
2011
2011
P298 - Évolution du diabète de la mucoviscidose sous répaglinide
M. Laib
,
D. Hubert
,
H. M. Pudar
2011
Corpus ID: 73372836
2010
2010
P201 Hypoglycémie prolongée sous répaglinide (Novonorm
O. Dupuy
,
L. Bordier
,
C. Vallet
,
H. Mayaudon
,
B. Bauduceau
2010
Corpus ID: 71576607
2007
2007
Le répaglinide Antidiabétiques oraux : portrait de famille (4e partie)
M. Gerson
2007
Corpus ID: 193234423
Apres la metformine, les sulfamides hypoglycemiants et les inhibiteurs des alpha-glucosidases intestinales, le « portrait de…
Expand
2006
2006
Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment
Mustafa Ozbek
,
M. Erdogan
,
+5 authors
M. Tüzün
Acta Diabetologica
2006
Corpus ID: 31626243
In this study, we investigated the effects of combining preprandial repaglinide to the insulin therapy for reducing the exogenous…
Expand
2000
2000
Compared with repaglinide sulphonylurea treatment in type 2 diabetes is associated with a 2.5-fold increase in symptomatic hypoglycaemia with blood glucose levels < 2.5 mmol/l
J. Kristensen
,
K. Frandsen
,
T. Bayer
,
P. Müller
2000
Corpus ID: 72072489
2000
2000
The impact of prandial repaglinide on eating behaviours and perceptions in type 2 diabetes
M. Dieken
,
C. Bauer
,
Kornelius Selenka
,
R. Landgraf
2000
Corpus ID: 57457597
1998
1998
REPAGLINIDE VERBESSERT DEN BLUTZUCKER UND DIE LEBENSQUALITAT
B. Hellwig
1998
Corpus ID: 79204158
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE